| 2023 | MAFLD might be better in identifying subjects with sarcopenia or cardiovascular risk than NAFLD: A nationwide study | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | Noninvasive risk assessment of hepatic decompensation in patients with hepatitis B virus-related liver cirrhosis | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | A machine learning model for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B | LIVER INTERNATIONAL |
| 2023 | A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone | AMERICAN JOURNAL OF GASTROENTEROLOGY |
| 2023 | Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2023 | Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association-National Cancer Center 2022 Criteria
| CANCER RESEARCH AND TREATMENT |
| 2023 | The clinical effect of antiviral therapy in patients with hepatitis B virus-related decompensated cirrhosis and undetectable DNA | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2023 | Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2023 | Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2023 | Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease | LIVER INTERNATIONAL |
| 2023 | Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment
| CANCER MEDICINE |
| 2023 | Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma | EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY |
| 2023 | Suboptimal Performance of Hepatocellular Carcinoma Prediction Models in Patients with Hepatitis B Virus-Related Cirrhosis
| DIAGNOSTICS |
| 2022 | ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| 2022 | Clinical characteristics and prognosis of Korean patients with hepatocellular carcinoma with respect to etiology
| Journal of Liver Cancer(대한간암학회지) |
| 2022 | Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease
| GUT AND LIVER |
| 2022 | Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model
| GASTROENTEROLOGY REPORT |
| 2022 | Prevalence and Risk Factors of Cardiovascular Disease in Patients with Chronic Hepatitis B | DIGESTIVE DISEASES AND SCIENCES |
| 2022 | A New Reporting System for Diagnosis of Hepatocellular Carcinoma in Chronic Hepatitis B With Clinical and Gadoxetic Acid-Enhanced MRI Features | JOURNAL OF MAGNETIC RESONANCE IMAGING |
| 2022 | Total Lesion Glycolysis on 18F-FDG PET/CT Is a Better Prognostic Factor Than Tumor Dose on 90Y PET/CT in Patients With Hepatocellular Carcinoma Treated With 90Y Transarterial Radioembolization | CLINICAL NUCLEAR MEDICINE |
| 2022 | Effects of Hepatic Impairment on the Pharmacokinetic Profile and Safety of Lobeglitazone | CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT |
| 2022 | Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study | LANCET GASTROENTEROLOGY & HEPATOLOGY |
| 2022 | Anti-Cancer Effects of YAP Inhibitor (CA3) in Combination with Sorafenib against Hepatocellular Carcinoma (HCC) in Patient-Derived Multicellular Tumor Spheroid Models (MCTS)
| CANCERS |
| 2022 | Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
| CANCERS |
| 2022 | Activated TAZ induces liver cancer in collaboration with EGFR/HER2 signaling pathways
| BMC CANCER |
| 2022 | Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria
| FRONTIERS IN MEDICINE |
| 2022 | Predictive Performance of CAGE-B and SAGE-B Models in Asian Treatment-Naive Patients Who Started Entecavir for Chronic Hepatitis B | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY |
| 2022 | Cost-effectiveness of chronic hepatitis C screening and treatment
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2022 | Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study | JOURNAL OF VIRAL HEPATITIS |
| 2022 | Expert consensus on the management of adverse events in patients receiving lenvatinib for hepatocellular carcinoma
| JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2022 | A Multi-Center, Double-Blind Randomized Controlled Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802 (Tenofovir Disoproxil Orotate) and Viread (Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients
| JOURNAL OF KOREAN MEDICAL SCIENCE |
| 2022 | Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study
| CANCERS |
| 2022 | Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
| GUT AND LIVER |
| 2022 | Liver-directed concurrent chemoradiotherapy versus sorafenib in hepatocellular carcinoma with portal vein tumor thrombus | JOURNAL OF CLINICAL ONCOLOGY |
| 2022 | Predictors of Sarcopenia in an Obese Asian Population | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL |
| 2022 | External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study
| CANCERS |
| 2022 | Validation of PH and Varices Risk Scores for Prediction of High-Risk Esophageal Varix and Bleeding in Patients with B-Viral Cirrhosis
| DIAGNOSTICS |
| 2022 | Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL | AMERICAN JOURNAL OF GASTROENTEROLOGY |
| 2022 | Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
| CANCERS |
| 2022 | Long-term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis B | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2022 | Transarterial Radioembolization for Unresectable Hepatocellular Carcinoma: Real-Life Efficacy and Safety Analysis of Korean Patients
| CANCERS |
| 2022 | Lung and lymph node metastases from hepatocellular carcinoma: Comparison of pathological aspects | LIVER INTERNATIONAL |
| 2021 | Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy
| CANCERS |
| 2021 | No influence of hepatic steatosis on the 3-year outcomes of patients with quiescent chronic hepatitis B | JOURNAL OF VIRAL HEPATITIS |
| 2021 | YAP/TAZ Suppress Drug Penetration Into Hepatocellular Carcinoma Through Stromal Activation | HEPATOLOGY |
| 2021 | History and future of hepatitis B virus control in South Korea
| CLINICAL AND MOLECULAR HEPATOLOGY |
| 2021 | Dickkopf-1 promotes angiogenesis by upregulating VEGF receptor 2-mediated mTOR/p70S6K signaling in hepatocellular carcinoma
| AMERICAN JOURNAL OF CANCER RESEARCH |
| 2021 | Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease
| JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE |
| 2021 | Risk assessment of hepatocellular carcinoma and liver-related events using ultrasonography and transient elastography in patients with chronic hepatitis B | JOURNAL OF VIRAL HEPATITIS |
| 2021 | Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B | JOURNAL OF VIRAL HEPATITIS |
(56119929100)
